Matches in SemOpenAlex for { <https://semopenalex.org/work/W4247359632> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4247359632 endingPage "50" @default.
- W4247359632 startingPage "45" @default.
- W4247359632 abstract "Introduction. Combination therapy is widely used in treatment of patients with arterial hypertension (AH) of high and very high cardiovascular risk. Fixed combinations (FC) of medications are preferable and it is important to develop new effective and safe ones. Organ-protective effects are also significant. Objective. To study antihypertensive effectiveness of new FC of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM), its influence on cardiometabolic risk factors and target lesions in metabolic disorder patients with AH of stages 1 or 2. Materials and methods. The study included 30 patients (13 male, 17 female, mean age 47.20±0.22 years) with AH of stages 1 or 2 and metabolic syndrome (MS). All patients underwent clinical assessment of blood pressure (BP); levels of serum cholesterol (SCL), high density lipoprotein (HDL), low density lipoprotein (LDL), triglyceride, creatinine, and glucose in oral glucose tolerance test; 24-hour blood pressure monitoring; central systolic blood pressure (CSBP); carotid-femoral pulse wave velocity (cfPWV), and intima-media complex thickness which were determined initially and after 6 months of therapy with FC. Results. The target level of BP was reached by 88% patients after treatment with Concor® AM. Significant deceleration of heart rate (from 74.95±2.20 to 68.81±1.13 bpm) and CSBP (from 151.7 to 132.6 mm Hg) were observed. Treatment with Concor® AM led to artery stiffness decrease evaluated by cfPWV decrease (from 14.21±0.45 to 12.1±0.23 m/s, p≤0.05). Conclusion. FC of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) was shown effective for AH treatment in patients with MS. Future research is recommended to investigate the effectiveness of FC therapy in a larger cohort of patients." @default.
- W4247359632 created "2022-05-12" @default.
- W4247359632 creator A5000330519 @default.
- W4247359632 creator A5004077073 @default.
- W4247359632 creator A5034172802 @default.
- W4247359632 creator A5051681824 @default.
- W4247359632 creator A5073619870 @default.
- W4247359632 creator A5073983590 @default.
- W4247359632 date "2017-03-15" @default.
- W4247359632 modified "2023-09-27" @default.
- W4247359632 title "Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients" @default.
- W4247359632 cites W1966108612 @default.
- W4247359632 cites W2043244508 @default.
- W4247359632 cites W2133882991 @default.
- W4247359632 cites W2160547085 @default.
- W4247359632 cites W2167557672 @default.
- W4247359632 cites W3016405830 @default.
- W4247359632 cites W3171237122 @default.
- W4247359632 cites W2089318135 @default.
- W4247359632 doi "https://doi.org/10.26442/sg29174" @default.
- W4247359632 hasPublicationYear "2017" @default.
- W4247359632 type Work @default.
- W4247359632 citedByCount "0" @default.
- W4247359632 crossrefType "journal-article" @default.
- W4247359632 hasAuthorship W4247359632A5000330519 @default.
- W4247359632 hasAuthorship W4247359632A5004077073 @default.
- W4247359632 hasAuthorship W4247359632A5034172802 @default.
- W4247359632 hasAuthorship W4247359632A5051681824 @default.
- W4247359632 hasAuthorship W4247359632A5073619870 @default.
- W4247359632 hasAuthorship W4247359632A5073983590 @default.
- W4247359632 hasBestOaLocation W42473596321 @default.
- W4247359632 hasConcept C126322002 @default.
- W4247359632 hasConcept C164705383 @default.
- W4247359632 hasConcept C2775850156 @default.
- W4247359632 hasConcept C2777097880 @default.
- W4247359632 hasConcept C2778163477 @default.
- W4247359632 hasConcept C2778319312 @default.
- W4247359632 hasConcept C2778913445 @default.
- W4247359632 hasConcept C2779646130 @default.
- W4247359632 hasConcept C2779670145 @default.
- W4247359632 hasConcept C2780306776 @default.
- W4247359632 hasConcept C71924100 @default.
- W4247359632 hasConcept C84393581 @default.
- W4247359632 hasConceptScore W4247359632C126322002 @default.
- W4247359632 hasConceptScore W4247359632C164705383 @default.
- W4247359632 hasConceptScore W4247359632C2775850156 @default.
- W4247359632 hasConceptScore W4247359632C2777097880 @default.
- W4247359632 hasConceptScore W4247359632C2778163477 @default.
- W4247359632 hasConceptScore W4247359632C2778319312 @default.
- W4247359632 hasConceptScore W4247359632C2778913445 @default.
- W4247359632 hasConceptScore W4247359632C2779646130 @default.
- W4247359632 hasConceptScore W4247359632C2779670145 @default.
- W4247359632 hasConceptScore W4247359632C2780306776 @default.
- W4247359632 hasConceptScore W4247359632C71924100 @default.
- W4247359632 hasConceptScore W4247359632C84393581 @default.
- W4247359632 hasIssue "1" @default.
- W4247359632 hasLocation W42473596321 @default.
- W4247359632 hasOpenAccess W4247359632 @default.
- W4247359632 hasPrimaryLocation W42473596321 @default.
- W4247359632 hasRelatedWork W2000084903 @default.
- W4247359632 hasRelatedWork W2078176077 @default.
- W4247359632 hasRelatedWork W2096310534 @default.
- W4247359632 hasRelatedWork W2097766117 @default.
- W4247359632 hasRelatedWork W2352601322 @default.
- W4247359632 hasRelatedWork W2373296552 @default.
- W4247359632 hasRelatedWork W2388261622 @default.
- W4247359632 hasRelatedWork W2806947749 @default.
- W4247359632 hasRelatedWork W3028759227 @default.
- W4247359632 hasRelatedWork W4247359632 @default.
- W4247359632 hasVolume "14" @default.
- W4247359632 isParatext "false" @default.
- W4247359632 isRetracted "false" @default.
- W4247359632 workType "article" @default.